Considering the mounting evidence implicating CTSB dysfunction in PD and the studies supporting CTSB and CTSL proteolytic effect on SNCA, we here investigate the mechanisms underlying the effect of SNCA turnover and examine the therapeutic potential of both proteases in preventing SNCA pathology. This evidence concerns the gene CTSB and Parkinson disease.